Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03077087 · ClinicalTrials.gov registry record · NA

Single-Stage Integra Reconstruction in Burns

A NA study, sponsored by HealthPartners Institute.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT03077087 is a NA study that was terminated before completion, run by HealthPartners Institute. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03077087, a NA study, was terminated before completion, sponsored by HealthPartners Institute.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

This is a prospective, descriptive, pilot case series involving patients with significant burns who are candidates for reconstruction with Integra®. Subjects would have a small area of the wound would, at the time of excision, have the smallest sheet of thin Integra® (125 cm2) placed and be immediately autografted with a 3:1 meshed split-thickness skin graft. Of note, 125 cm2 represents approximately 0.7% of an average sized patient's total body surface area, so for even the smallest burns in our proposed trial, this area would represent a small portion of the patient's area of injury. The remaining injury areas would be covered with standard-thickness Integra® only.

Interventions

  • DEVICE thin Integra® (125 cm2)

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2017-04-10
Est. Completion 2019-07-24
Phase NA

Sponsor

HealthPartners Institute

146 total trials

What the Registry Record Tells You About NCT03077087

The ClinicalTrials.gov registry entry for NCT03077087 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which thin Integra® (125 cm2) is the first listed.

NCT03077087 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03077087 about?

NCT03077087 is a clinical study titled "Single-Stage Integra Reconstruction in Burns". This is a prospective, descriptive, pilot case series involving patients with significant burns who are candidates for reconstruction with Integra®. Subjects would have a small area of the wound would, at the time of excision, have the smallest sheet of thin Integra® (125 cm2) placed and be immediat...

What is the current status of trial NCT03077087?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2017-04-10. Estimated completion is 2019-07-24.

What interventions are being tested in trial NCT03077087?

The interventions under investigation include: thin Integra® (125 cm2) (DEVICE).

Who is sponsoring clinical trial NCT03077087?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.